Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care products, have entered into an exclusive licensing agreement…Read More
Strides Shasun Limited’s wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval for Cyproheptadine Hydrochloride Tablets USP, 4 mg from the United States Food and Drug Administration (USFDA)….Read More
Cipla has launched an authorized generic version of Aloxi in the United States of America under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva….Read More
Pfizer Inc. and Allogene Therapeutics Inc. have entered into an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, an investigational immune…Read More
Suven Life Sciences Ltd has been granted one product patent from Canada (2907620) corresponding to the new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases and…Read More
Zydus Cadila has received the final approval from the USFDA to market Metoprolol Succinate extended-release tablets USP in the strengths of 25 mg, 50 mg, 100 mg, and 200 mg….Read More
Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory, Pune (CSIR-NCL) and Department of Science and Technology, Delhi (DST) for conducting research on a continuous purification process development…Read More
Recent Comments